Information on Macrocephaly/autism syndrome

Basic details

Name: Macrocephaly/autism syndrome | Acronym:
Alt. names:

Gene: PTEN | MOI: Autosomal dominant | Mechanism of action:

No. of cases in DB: 0 | First reported in: 2005

Last updated on: 2023-02-28 16:41:18 by

OMIM: 605309

Orphanet: -

MONDO: -

DOID: -

ClinGen:

Description

Surveillance is indicated to screen for the presence of neoplasms (including regular thyroid ultrasound, dermatologic examinations, breast screening including mammogram and/or MRI, transvaginal ultrasound and/or endometrial biopsy, colonoscopy, renal imaging, and other screening as specifically indicated by family or personal medical history), which may allow early diagnosis and treatment, which may be beneficial related to morbidity and mortality. Evidence for association with some cancerous processes is unclear,and the division into many separate disorders is likely specious. Refs. PMIDs: 5345120; 5091590; 957004; 7449178; 7079022; 6881215; 6507473; 3707175; 3698331; 3340479; 1336932; 1350505; 8207516; 9140396; 9286463; 9399897; 9241266; 9259288; 9545417; 9662392; 9832032; 9832031; 9425889; 9445133; 9856571; 10353779; 10400993; 10234502; 11238682; 11748304; 12085208; 11875759; 12938083; 14518069; 12833416; 14566704; 15805158; 16704655; 16752378; 17286265; 17526800; 17526801; 17847000; 18781191; 21659347; 21633361; 20301661; 21956414; 22595938; 22970944; 23335809; 23344409

Management

Description of management option has not been reviewed yet.

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

0 reported cases added to GenIA

SubjectID Sex Fam.ID AD AFM Validity Country Population Reference & Pub.code

AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).

Summary of clinical findings

[Considering only Definitive and Possible cases]

Rank Clinical term Present Absent Unreported
1 Autismarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
2 Infantile onsetarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
3 Postnatal macrocephalyarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
4 Delayed speech and language developmentarrow icon 2 (66.7%) 0 (0.0%) 1 (33.3%)
5 Global developmental delayarrow icon 2 (66.7%) 0 (0.0%) 1 (33.3%)
6 Penile frecklingarrow icon 2 (66.7%) 0 (0.0%) 1 (33.3%)
7 Prominent foreheadarrow icon 2 (66.7%) 0 (0.0%) 1 (33.3%)
8 Coarse hairarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
9 Cutis laxaarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
10 Depressed nasal bridgearrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
11 Perivascular spacesarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
12 Epicanthusarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
13 High palatearrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
14 Hydrocele testisarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
15 Muscular hypotoniaarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
16 Joint hypermobilityarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
17 Large for gestational agearrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
18 Midface retrusionarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
19 Overgrowtharrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
20 Recurrent otitis mediaarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
21 Short attention spanarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
22 Speech apraxiaarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

Summary of treatment outcomes

[Considering only Definitive and Possible cases]

Treatment ⓘ Responses & clinical indications

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.